Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Guss

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|January 4, 2018
TLR2 agonism reverses chemotherapy-induced neutropenia in <i>Macaca fascicularis</i>Nicholas J Laping, Michael P DeMartino, Joshua E Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|January 4, 2018
TLR2 agonism reverses chemotherapy-induced neutropenia in <i>Macaca fascicularis</i>Nicholas J Laping, Michael P DeMartino, Joshua E Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
Pageof 2